The True Cost of Advanced Therapy Logistics
Cost conversations in biopharma cold chain often start in the wrong place. Teams focus...
read Details
Understanding + Applying Annex 1: New EU GMP
Understanding + Applying Annex 1: New EU GMP
The global regulatory experts at Modality Solutions provide a detailed, tactical approach for meeting the new requirements for container closure integrity (CCI) of sterile pharmaceutical products detailed in the revised Annex 1 EU GMP.
Download the slide deck created by industry experts, Andrew Larrigan and Carson Dickey to understand how the changes to EU Annex 1 will impact your cold chain strategy for container closure integrity.
Receive this webinar to your email
You may also like
Antibody-Drug Conjugate (ADC) Logistics: Managing Potency, Stability, and Safe Handling
Antibody-drug conjugates (ADCs) are a revolutionary class of biopharmaceuticals that combine the precision of...
read Details
CMC and Quality in Advanced Therapy Supply Chains: Where Compliance Meets the Clock
There is a particular kind of pressure that comes with managing Chemistry, Manufacturing, and...
read Details